Vol. 38 No. 5 (2021): Octubre
Clinical Case

Late diagnosis nodular lepromatous leprosy from the Peruvian Amazon, with development of a type 2 reaction

Miguel Villegas-Chiroque
Hospital Regional Lambayeque Perú Universidad Nacional Pedro Ruiz Gallo Lambayeque
Bio
Winston Maldonado-Gómez
Hospital Regional Lambayeque Perú Universidad Nacional Pedro Ruiz Gallo Lambayeque
Bio
Walter Espino-Saavedra
Hospital Regional Lambayeque Perú
Bio
Roberto Ventura-Flores
Hospital Regional Lambayeque Perú Universidad Nacional Pedro Ruiz Gallo Lambayeque
Bio

Published 2021-11-18

How to Cite

1.
Villegas-Chiroque M, Maldonado-Gómez W, Espino-Saavedra W, Ventura-Flores R. Late diagnosis nodular lepromatous leprosy from the Peruvian Amazon, with development of a type 2 reaction. Rev. Chilena. Infectol. [Internet]. 2021 Nov. 18 [cited 2026 Mar. 13];38(5). Available from: https://revinf.cl/index.php/revinf/article/view/1096

Abstract

Leprosy or Hansen’s disease is one of the classic neglected diseases that still persists in Peru. The infection is caused by Mycobacterium leprae. The disease varies in a wide range of manifestations from tuberculoid (paucibacillary) to lepromatous (multibacillary) leprosy. We present the case of a 55-year-old man, farmer and wood extractor, from the Peruvian Amazon with old infiltrating cutaneous lesions on the face, neck, thorax, abdomen and extremities. The smear and biopsy examinations confirm the presence of acid-alcohol-resistant bacilli compatible with leprosy. It is concluded, with a long delay, it was a case of nodular lepromatous leprosy. He received therapy with rifampicin, dapsone and clofamizine for two years with slow progressive improvement; however, he presented an erythema nodosum leprosum (type 2 reaction) with response to corticosteroids and thalidomide.